T 1713/19 (Toxin A-Toxin B fusion/VALNEVA) of 09.11.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T171319.20211109
- Date of decision
- 9 November 2021
- Case number
- T 1713/19
- Petition for review of
- -
- Application number
- 11769799.5
- IPC class
- C07K 14/33A61K 39/08
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereof
- Applicant name
- Valneva Austria GmbH
Valneva USA, Inc. - Opponent name
- GlaxoSmithKline Biologicals SA
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54(2)European Patent Convention Art 54(3)European Patent Convention Art 56European Patent Convention Art 83European Patent Convention R 103(4)(a)
- Keywords
- Amendments - added subject-matter (no)
Amendments - broadening of claim (no)
Novelty - (yes)
Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- T 1038/19
Order
For these reasons it is decided that:
The appeal is dismissed.